Chemical and Microbiological Determination of Vitamin B 6. In: Glick D, editor. Methods of Biochemical Analysis. Hoboken: John Wiley & Sons, Inc.; 1964. pp. 183-276. [DOI: 10.1002/9780470110300.ch5]

Effects of different levels of vitamin B6 in tank water on the Nile tilapia (Oreochromis niloticus): growth performance, blood biochemical parameters, intestine and liver histology, and intestinal enzyme activity

According to the importance of vitamin B₆ (pyridoxine) as a water-soluble vitamin on the physiological conditions of aquatic animals, the present study aimed to investigate effects of different concentrations of this vitamin in recycle system culture water on the Nile tilapia (Oreochromis niloticus). Treatments including 0 (control), 10, 20, 30, and 40 mg L^-1 vitamin B₆ were adjusted in triplicate recirculating systems. Each of the experimental tanks (100 L) was stocked 15 fingerling Nile tilapia during 60-day experimental period. According to the findings, weight gain in treatments of 30 and 40 mg L^-1 pyridoxine was significantly higher than the other treatments while blood cortisol hormone in the treatment of 40 mg L^-1 was significantly highest among the treatments. In addition, mid-intestine trypsin activity in the treatment of 40 mg L^-1 was significantly higher than the other treatments. The histological analysis of the intestine showed that the number of mucus-secreting cells significantly decreased in treatments of 30 and 40 mg L^-1. Our findings here suggest that pyridoxine can possibly be absorbed by the Nile tilapia's body through culture water and it seems 20-30 mg L^-1 pyridoxine in the culture water is the optimal concentration for the Nile tilapia juveniles in recycle system culture.

Analyzing B-vitamins in Human Milk: Methodological Approaches

According to the World Health Organization (WHO), infants should be exclusively breastfed for the first six months of life. However, there is insufficient information about the concentration of nutrients in human milk. For some nutrients, including B-vitamins, maternal intake affects their concentration in human milk but the extent to which inadequate maternal diets affect milk B-vitamin content is poorly documented. Little is known about infant requirements for B-vitamins; recommendations are generally set as Adequate Intakes (AI) calculated on the basis of the mean volume of milk (0.78 L/day) consumed by infants exclusively fed with human milk from well-nourished mothers during the first six months, and the concentration of each vitamin in milk based on reported values. Methods used for analyzing B-vitamins, commonly microbiological, radioisotope dilution or more recently chromatographic, coupled with UV, fluorometric and MS detection, have rarely been validated for the complex human milk matrix. Thus the validity, accuracy, and sensitivity of analytical methods is important for understanding infant requirements for these nutrients, the maternal intakes needed to support adequate concentrations in breast milk. This review summarizes current knowledge on methods used for analyzing the B-vitamins thiamin, riboflavin, niacin, vitamin B-6 and pantothenic acid, vitamin B-12, folate, biotin, and choline in human milk, their chemical and physical properties, the different forms and changes in concentration during lactation, and the effects of deficiency on the infant.

Mutants of Escherichia coli with a growth requirement for either lysine or pyridoxine

Two distinct phenotypic classes of lysine requiring auxotrophs of Escherichia coli are described. Mutants of the LysA class produce little or no active diaminopimelic acid (DAP) decarboxylase and specifically require lysine for growth. Mutants of the LysB class produce a cryptic DAP decarboxylase which can be activated both in vivo and in vitro by higher than normal levels of its cofactor, pyridoxal 5'-phosphate. The LysB mutants have an alternate requirement for lysine or pyridoxine. Both LysA and LysB mutations map at 55 min, close to the thyA locus of E. coli. The association between pyridoxal phosphate and DAP decarboxylase appears to be much weaker in LysB mutants than in wild-type bacteria, and the mutant enzyme also sediments more slowly than wild-type enzyme in sucrose density gradients. The results suggest that the LysB mutations alter a specific region (or subunit) of the enzyme molecule which is needed to stabilize the binding of pyridoxal phosphate. These studies help to resolve certain contradictory observations on DAP decarboxylase reported earlier and may have relevance to pyridoxal phosphate enzymes in general. Prototrophic revertants of LysB mutants arise by second site mutations that result in increased availability of intracellular pyridoxal phosphate. These revertants appear to be derepressed for pyridoxine biosynthesis.